Gebruikswaarde onderzoek bloemkool : biologische teelt, herfst, 2001 en 2002

Nieuwe bloemkoolrassen zijn de laatste jaren wel op hun gebruikswaarde voor de gangbare teelt getoetst, maar niet op hun geschiktheid voor de biologische teelt. Voor de biologische teelt wordt een grotere resistentie tegen ziekten en plagen vereist. Biologisch geteelde bloemkool wordt op de versmarkt afgezet, maar ook veel verkocht aan de industrie als "roosjes". Voor deze afzetwijze worden aan de rassen speciale eisen gesteld

Efficiënt gebruik van snijmaïs. Deel 2: invloed rastype en oogststadium op opbrengst en kwaliteit = Efficient use of silage maize. Part 2: effect of genotype and harvest stage on crop yield and quality

In the period 2003-2005 effects of genotypes and maturity stage on yield, quality, conservation an nutrition were investigated. This research was focusing on crop yield and quality. It was concluded that there was hardly any difference in optimum harvest stage between genotypes. The optimum harvest stage varied from 35 to 40 % dry matte

Gebruikswaarde onderzoek bloemkool : biologische teelt, herfst, 2001 en 2002

Nieuwe bloemkoolrassen zijn de laatste jaren wel op hun gebruikswaarde voor de gangbare teelt getoetst, maar niet op hun geschiktheid voor de biologische teelt. Voor de biologische teelt wordt een grotere resistentie tegen ziekten en plagen vereist. Biologisch geteelde bloemkool wordt op de versmarkt afgezet, maar ook veel verkocht aan de industrie als "roosjes". Voor deze afzetwijze worden aan de rassen speciale eisen gesteld

Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients

PURPOSE: Several studies have shown survival benefit by autologous stem cell transplantation in acute myeloid leukemia (AML) after purging of grafts. This has, however, not been confirmed in randomized studies due to high toxicity of purging modalities for normal progenitor/stem cells. In this study, we investigated whether positive selection for CD34+ and/or CD133+ cells, which results in high recovery of normal progenitor/stem cells, is applicable for purging AML grafts. EXPERIMENTAL DESIGN: Positive selections of normal stem cells using CD34 and/or CD133 can be done if one or both markers are absent or have dim expression and remain so during the course of the disease. Marker expressions in newly diagnosed AML were measured with flow cytometry using a cutoff value for positivity of 1%. Stability of marker expression was studied by pairwise comparison of material at diagnosis and relapse. Leukemia associated phenotype expression was used to measure the efficacy of tumor cell reduction. RESULTS: In newly diagnosed AML (n = 165), we found no CD34 and/or CD133 expression in 32% of the cases and dim expression in 20% of the cases. No increase in the percentage of CD34+ cells (n = 44) and CD133+ cells (n = 29) was found in corresponding relapses. Positive selection using grafts contaminated with AML blasts, showing either no or dim expression of CD34 or CD133, resulted in a 3 to 4 log tumor cell reduction (n = 11) with median 50% recovery of normal stem cells. CONCLUSIONS: Purging by positive selection of CD34+ and/or CD133+ cells can safely, effectively, and reproducibly be applied in about 50% of AML cases

The relationship between depressive symptoms, general psychopathology, and well-being in patients with major depressive disorder

Contains fulltext : 226701.pdf (Publisher’s version ) (Open Access)Objective: In mental health care, treatment effects are commonly monitored by symptom severity measures. This study aimed to investigate the relationship between symptom severity and well-being in the treatment of patients with major depressive disorder (MDD). Methods: Adult MDD outpatients (n = 77) were administered the Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR), the Outcome Questionnaire (OQ-45), and the Mental Health Continuum-Short Form (MHC-SF) before treatment and 6 months later. Results: Symptom severity correlated moderately with well-being at baseline and strongly at follow-up. Reliable change index scores showed improvement on the QIDS-SR, OQ-45, and MHC-SF in 65%, 59%, and 40%, respectively. A quarter of patients improved in symptom severity but not well-being (Inventory of Depressive Symptomatology - Self-Report [IDS-SR]: 25%; OQ-45: 24%). Conclusion: Findings suggest that symptom severity and subjective well-being are related, but distinct concepts. Several reasons for the stronger improvements in symptoms than in well-being are discussed.15 p

Ultrasound Imaging for Tailored Treatment of Patients With Acute Shoulder Pain

PURPOSE: The objective of this study was to assess the frequencies of ultrasound findings in patients with acute rotator cuff disorders in family medicine. METHODS: In a prospective observational study, 129 patients aged 18 to 65 years with acute shoulder pain in whom the family physician suspected rotator cuff disease underwent ultrasound imaging. RESULTS: Rotator cuff disease was present in 81% of the patients, and 50% of them had multiple disorders. Calcific tendonitis was the most frequently diagnosed specific disorder. An age of 40 years or older was most strongly related to rotator cuff disease. CONCLUSIONS: Ultrasound imaging enables family physicians to rationalize treatment in nearly all patients who are aged 40 years and older with acute shoulder pain

Efficiënt gebruik van snijmaïs. Deel 2: invloed rastype en oogststadium op opbrengst en kwaliteit = Efficient use of silage maize. Part 2: effect of genotype and harvest stage on crop yield and quality

In the period 2003-2005 effects of genotypes and maturity stage on yield, quality, conservation an nutrition were investigated. This research was focusing on crop yield and quality. It was concluded that there was hardly any difference in optimum harvest stage between genotypes. The optimum harvest stage varied from 35 to 40 % dry matte

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.

or =3 months. In conclusion, MRD parameter assessment at different stages of disease is highly reliable in predicting survival and forthcoming relapses in AML